Are you Dr. Mawad?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 73 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
825 Eastlake Ave E
Seattle, WA 98109Phone+1 206-520-5000Fax+1 206-215-6165- Is this information wrong?
Summary
- Dr. Raya Mawad, MD is an oncologist in Seattle, Washington. She is currently licensed to practice medicine in Washington and California. She is affiliated with Fred Hutchinson Cancer Center and Swedish First Hill Campus.
Education & Training
- University of WashingtonFellowship, Hematology and Medical Oncology, 2010 - 2013
- University of California (San Francisco)Residency, Internal Medicine, 2007 - 2009
- University of WashingtonInternship, Internal Medicine, 2006 - 2007
- Baylor College of MedicineClass of 2006
Certifications & Licensure
- CA State Medical License 2008 - Present
- WA State Medical License 2006 - 2025
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014
Clinical Trials
- Study of PTC299 (Emvododstat) in Relapsed/Refractory Acute Leukemias Start of enrollment: 2018 Oct 29
Publications & Presentations
PubMed
- 2 citationsPhase 1 study of vibecotamab identifies an optimized dose for treatment of relapsed/refractory acute myeloid leukemia.Farhad Ravandi, Asad Bashey, James Foran, Wendy Stock, Raya Mawad, Nicholas Short, Musa Yilmaz, Hagop Kantarjian, Olatoyosi Odenike, Anand Patel, Raman Garcha, William...> ;Blood Advances. 2023 Nov 14
- 1 citationsThe role of adjuvant chemotherapy in the management of acute promyelocytic leukemia differentiation syndrome.Dominic LaBella, Samuel Regan, Heiko Konig, Daniel N Egan, Neil A Bailey, Raya Mawad, Morgan Gilbert, John M Pagel, Jeffrey J Pu> ;Frontiers in Oncology. 2022 Jan 1
- 80 citationsKTE-X19 anti-CD19 CAR T-cell therapy in adult relapsed/refractory acute lymphoblastic leukemia: ZUMA-3 phase 1 results.Bijal D. Shah, Michael R. Bishop, Olalekan O. Oluwole, Aaron C Logan, Maria R. Baer, William B. Donnellan, Kristen M. O'Dwyer, Houston Holmes, Martha Arellano, Armin G...> ;Blood. 2021 Jul 8
- Join now to see all
Other Languages
- Spanish, French
Hospital Affiliations
- Swedish First Hill CampusSeattle, Washington
- Fred Hutchinson Cancer CenterSeattle, Washington